BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24760139)

  • 1. Molecular signatures differentiate immune states in type 1 diabetic families.
    Chen YG; Cabrera SM; Jia S; Kaldunski ML; Kramer J; Cheong S; Geoffrey R; Roethle MF; Woodliff JE; Greenbaum CJ; Wang X; Hessner MJ
    Diabetes; 2014 Nov; 63(11):3960-73. PubMed ID: 24760139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic levels of CCL2, CCL3, CCL4 and CXCL8 differ according to age, time period and season among children newly diagnosed with type 1 diabetes and their healthy siblings.
    Thorsen SU; Eising S; Mortensen HB; Skogstrand K; Pociot F; Johannesen J; Svensson J;
    Scand J Immunol; 2014 Dec; 80(6):452-61. PubMed ID: 25201044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of coordination and order in transcription regulation of innate and adaptive immunity genes in type 1 diabetes.
    Gao S; Wolanyk N; Chen Y; Jia S; Hessner MJ; Wang X
    BMC Med Genomics; 2017 Jan; 10(1):7. PubMed ID: 28143555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma-induced signatures reveal an extracellular milieu possessing an immunoregulatory bias in treatment-naive paediatric inflammatory bowel disease.
    Gurram B; Salzman NH; Kaldunski ML; Jia S; Li BU; Stephens M; Sood MR; Hessner MJ
    Clin Exp Immunol; 2016 Apr; 184(1):36-49. PubMed ID: 26660358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal induction of immunoregulatory processes coincides with age-dependent resistance to viral-induced type 1 diabetes.
    Chen YG; Mordes JP; Blankenhorn EP; Kashmiri H; Kaldunski ML; Jia S; Geoffrey R; Wang X; Hessner MJ
    Genes Immun; 2013 Sep; 14(6):387-400. PubMed ID: 23739610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enterovirus Neutralizing Antibodies, Monocyte Toll Like Receptors Expression and Interleukin Profiles Are Similar Between Non-affected and Affected Siblings From Long-Term Discordant Type 1 Diabetes Multiplex-Sib Families: The Importance of HLA Background.
    Bergamin CS; Pérez-Hurtado E; Oliveira L; Gabbay M; Piveta V; Bittencourt C; Russo D; Carmona RC; Sato M; Dib SA
    Front Endocrinol (Lausanne); 2020; 11():555685. PubMed ID: 33071971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered chemokine levels in individuals at risk of Type 1 diabetes mellitus.
    Hanifi-Moghaddam P; Kappler S; Seissler J; Müller-Scholze S; Martin S; Roep BO; Strassburger K; Kolb H; Schloot NC
    Diabet Med; 2006 Feb; 23(2):156-63. PubMed ID: 16433713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-Scale Discovery and Validation Studies Demonstrate Significant Reductions in Circulating Levels of IL8, IL-1Ra, MCP-1, and MIP-1β in Patients With Type 1 Diabetes.
    Purohit S; Sharma A; Hopkins D; Steed L; Bode B; Anderson SW; Reed JC; Steed RD; Yang T; She JX
    J Clin Endocrinol Metab; 2015 Sep; 100(9):E1179-87. PubMed ID: 26158606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis of CD4+ CD25(high) T cells in type 1 diabetes may be partially mediated by IL-2 deprivation.
    Jailwala P; Waukau J; Glisic S; Jana S; Ehlenbach S; Hessner M; Alemzadeh R; Matsuyama S; Laud P; Wang X; Ghosh S
    PLoS One; 2009 Aug; 4(8):e6527. PubMed ID: 19654878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A unique T cell subset described as CD4loCD40+ T cells (TCD40) in human type 1 diabetes.
    Waid DM; Wagner RJ; Putnam A; Vaitaitis GM; Pennock ND; Calverley DC; Gottlieb P; Wagner DH
    Clin Immunol; 2007 Aug; 124(2):138-48. PubMed ID: 17560173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treg gene signatures predict and measure type 1 diabetes trajectory.
    Pesenacker AM; Chen V; Gillies J; Speake C; Marwaha AK; Sun A; Chow S; Tan R; Elliott T; Dutz JP; Tebbutt SJ; Levings MK
    JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30730852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High T-helper-1 cytokines but low T-helper-3 cytokines, inflammatory cytokines and chemokines in children with high risk of developing type 1 diabetes.
    Stechova K; Bohmova K; Vrabelova Z; Sepa A; Stadlerova G; Zacharovova K; Faresjö M
    Diabetes Metab Res Rev; 2007 Sep; 23(6):462-71. PubMed ID: 17315139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low expression of CD39(+) /CD45RA(+) on regulatory T cells (Treg ) cells in type 1 diabetic children in contrast to high expression of CD101(+) /CD129(+) on Treg cells in children with coeliac disease.
    Åkesson K; Tompa A; Rydén A; Faresjö M
    Clin Exp Immunol; 2015 Apr; 180(1):70-82. PubMed ID: 25421756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXP3+ Regulatory T Cell Compartment Is Altered in Children With Newly Diagnosed Type 1 Diabetes but Not in Autoantibody-Positive at-Risk Children.
    Viisanen T; Gazali AM; Ihantola EL; Ekman I; Näntö-Salonen K; Veijola R; Toppari J; Knip M; Ilonen J; Kinnunen T
    Front Immunol; 2019; 10():19. PubMed ID: 30723474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional signatures as a disease-specific and predictive inflammatory biomarker for type 1 diabetes.
    Levy H; Wang X; Kaldunski M; Jia S; Kramer J; Pavletich SJ; Reske M; Gessel T; Yassai M; Quasney MW; Dahmer MK; Gorski J; Hessner MJ
    Genes Immun; 2012 Dec; 13(8):593-604. PubMed ID: 22972474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for association of the TCF7 locus with type I diabetes.
    Erlich HA; Valdes AM; Julier C; Mirel D; Noble JA;
    Genes Immun; 2009 Dec; 10 Suppl 1(Suppl 1):S54-9. PubMed ID: 19956102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting edge: Increased IL-17-secreting T cells in children with new-onset type 1 diabetes.
    Marwaha AK; Crome SQ; Panagiotopoulos C; Berg KB; Qin H; Ouyang Q; Xu L; Priatel JJ; Levings MK; Tan R
    J Immunol; 2010 Oct; 185(7):3814-8. PubMed ID: 20810982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 1 diabetes in the Spanish population: additional factors to class II HLA-DR3 and -DR4.
    Urcelay E; Santiago JL; de la Calle H; Martínez A; Méndez J; Ibarra JM; Maluenda C; Fernández-Arquero M; de la Concha EG
    BMC Genomics; 2005 Apr; 6():56. PubMed ID: 15842729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extreme genetic risk for type 1A diabetes.
    Aly TA; Ide A; Jahromi MM; Barker JM; Fernando MS; Babu SR; Yu L; Miao D; Erlich HA; Fain PR; Barriga KJ; Norris JM; Rewers MJ; Eisenbarth GS
    Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14074-9. PubMed ID: 16966600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered immune profile from pre-diabetes to manifestation of type 1 diabetes.
    Rydén A; Faresjö M
    Diabetes Res Clin Pract; 2013 Apr; 100(1):74-84. PubMed ID: 23485080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.